Key Findings - Design: Prospective, single-arm, open-label study - Participants: 16 adults with obesity and type 2 diabetes - Intervention: Tirzepatide 2.5 mg (4 weeks) 5 mg (8 weeks) Metabolic Improvements - Glucose infusion rate (GIR) from 3.21 to 5.16 mg/min/kg - HbA1c from 7.95% to 6.14% - Body weight by 4.9 kg (5%) - Fat mass by 9.1%, muscle mass by 1.8% - Glucagon from 28.8 to 20.8 pg/ml No Correlation Found - GIR changes werent significantly linked to other clinical variables Your Voice Matters: As GLP-1/GIP therapies evolve, should early improvements in insulin sensitivity influence how we define treatment success beyond weight loss and HbA1c
Unraveling, contributing factors to the severity of postprandial hypoglycemia after gastric bypass surgery
For the injection, the gestational sac must not be visible yet.] When asked what the injection is, the response was methotrexate, or MTX
There is no month-to-month option
"The council regulates doctors who are registered to practise in New Zealand, but we do not have jurisdiction over individuals or companies overseas who may create these false pages
Because our bodies are constantly exposed to environmental stressors and free radicals, providing daily antioxidant support can help maintain a healthy balance
